Genetic or pharmacological inhibition of farnesyl diphosphate farnesyl transferase delayed tumor growth and promoted CD8+ T-cell infiltration through PI3K/AKT signaling, indicating the potential targeting of cholesterol biosynthesis and autophagy to combat PDAC [112]. Here, AKT1 is linked to neoplasm.